BCM
BIOC

Bridgeway Capital Management’s Biocept, Inc. BIOC Stock Holding History

Bridgeway Capital Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,140
Closed -$32K – 1488
2023
Q1 		$32K Sell
3,140
-508
-14% -$7.35K ﹤0.01% 1342
2022
Q4 		$58K Hold
3,648
– – ﹤0.01% 1284
2022
Q3 		$101K Hold
3,648
– – ﹤0.01% 1265
2022
Q2 		$103K Buy
3,648
+518
+17% +$23.6K ﹤0.01% 1219
2022
Q1 		$218K Buy
+3,130
New +$246K ﹤0.01% 1156

Other funds holding BIOC

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bridgeway Capital Management's BIOC Position: Q2 2023 in Review

Bridgeway Capital Management sold out of Biocept, Inc. (BIOC) in Q2 2023, closing a stake of 3,140 shares — an estimated $32K sold.

Bridgeway Capital Management first reported a position in BIOC in Q1 2022 and held it in 5 quarters. The position peaked at $218K in Q1 2022. 11 funds tracked by Wall St. Rank hold BIOC as of Q2 2023.

  • Bridgeway Capital Management reported no remaining Biocept, Inc. position as of Q2 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 3,140 Biocept, Inc. shares in Q2 2023, an estimated $32K.
  • Bridgeway Capital Management first reported a position in Biocept, Inc. in Q1 2022 and held it in 5 quarters.
  • Bridgeway Capital Management's Biocept, Inc. position peaked at $218K in Q1 2022.
  • 11 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.